aluates Reports

$ 0.0

Automative

Global Anticoagulant Reversal Agent Market Research Report 2026

Published Date: 2026-01-30

Report Code: QYRE-Auto-4J18533

Global Anticoagulant Reversal Agent Market Research Report 2024

BUY CHAPTERS

Global Anticoagulant Reversal Agent Market Research Report 2026

Code: QYRE-Auto-4J18533

Report

2026-01-30

Pages:119

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

DSM

AdvaCare

Innopharma

Suicheng Pharmaceutical

Cheng Yi Pharmaceutical

Wuhu Kangqi Pharmaceuticals

Jiangsu Huayang Pharmaceutical

Brilliant Pharmaceutical

Shandong Guangtongbao Pharmaceuticals

Bayer

Bristol Myers Squibb Company

eXIthera Pharmaceuticals

Ionis Pharmaceuticals

Cambryn Biologics

Anticoagulant Reversal Agent Market

The global Anticoagulant Reversal Agent market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Anticoagulant reversal agent is a medication or substance used to counteract the effects of anticoagulants. Anticoagulants, also known as blood thinners, are prescribed to prevent or treat blood clots. However, in some situations, such as when a patient experiences excessive bleeding or needs to undergo a surgical procedure, it may be necessary to reverse the anticoagulant's effects.

The North American market for Anticoagulant Reversal Agent is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Anticoagulant Reversal Agent is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Anticoagulant Reversal Agent in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Anticoagulant Reversal Agent include DSM, AdvaCare, Innopharma, Suicheng Pharmaceutical, Cheng Yi Pharmaceutical, Wuhu Kangqi Pharmaceuticals, Jiangsu Huayang Pharmaceutical, Brilliant Pharmaceutical, Shandong Guangtongbao Pharmaceuticals, Bayer AG, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Anticoagulant Reversal Agent market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anticoagulant Reversal Agent. The Anticoagulant Reversal Agent market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Anticoagulant Reversal Agent market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Anticoagulant Reversal Agent manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Anticoagulant Reversal Agent Market Report

Report Metric	Details
Report Name	Anticoagulant Reversal Agent Market
Segment by Type	Injection Fluid Tablet Others
Segment by Application	Hospital Research Institute Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	DSM, AdvaCare, Innopharma, Suicheng Pharmaceutical, Cheng Yi Pharmaceutical, Wuhu Kangqi Pharmaceuticals, Jiangsu Huayang Pharmaceutical, Brilliant Pharmaceutical, Shandong Guangtongbao Pharmaceuticals, Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics, eXithera Pharmaceuticals, Ionis Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Anticoagulant Reversal Agent companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Anticoagulant Reversal Agent Market report?

Ans: The main players in the Anticoagulant Reversal Agent Market are DSM, AdvaCare, Innopharma, Suicheng Pharmaceutical, Cheng Yi Pharmaceutical, Wuhu Kangqi Pharmaceuticals, Jiangsu Huayang Pharmaceutical, Brilliant Pharmaceutical, Shandong Guangtongbao Pharmaceuticals, Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics, eXithera Pharmaceuticals, Ionis Pharmaceuticals

What are the Application segmentation covered in the Anticoagulant Reversal Agent Market report?

Ans: The Applications covered in the Anticoagulant Reversal Agent Market report are Hospital, Research Institute, Others

What are the Type segmentation covered in the Anticoagulant Reversal Agent Market report?

Ans: The Types covered in the Anticoagulant Reversal Agent Market report are Injection Fluid, Tablet, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anticoagulant Reversal Agent Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Injection Fluid

1.2.3 Tablet

1.2.4 Others

1.3 Market by Application

1.3.1 Global Anticoagulant Reversal Agent Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Research Institute

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Anticoagulant Reversal Agent Market Perspective (2021–2032)

2.2 Global Anticoagulant Reversal Agent Growth Trends by Region

2.2.1 Global Anticoagulant Reversal Agent Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Anticoagulant Reversal Agent Historic Market Size by Region (2021–2026)

2.2.3 Anticoagulant Reversal Agent Forecasted Market Size by Region (2027–2032)

2.3 Anticoagulant Reversal Agent Market Dynamics

2.3.1 Anticoagulant Reversal Agent Industry Trends

2.3.2 Anticoagulant Reversal Agent Market Drivers

2.3.3 Anticoagulant Reversal Agent Market Challenges

2.3.4 Anticoagulant Reversal Agent Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Anticoagulant Reversal Agent Players by Revenue

3.1.1 Global Top Anticoagulant Reversal Agent Players by Revenue (2021–2026)

3.1.2 Global Anticoagulant Reversal Agent Revenue Market Share by Players (2021–2026)

3.2 Global Top Anticoagulant Reversal Agent Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Anticoagulant Reversal Agent Revenue

3.4 Global Anticoagulant Reversal Agent Market Concentration Ratio

3.4.1 Global Anticoagulant Reversal Agent Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Reversal Agent Revenue in 2025

3.5 Global Key Players of Anticoagulant Reversal Agent Head Offices and Areas Served

3.6 Global Key Players of Anticoagulant Reversal Agent, Products and Applications

3.7 Global Key Players of Anticoagulant Reversal Agent, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Anticoagulant Reversal Agent Breakdown Data by Type

4.1 Global Anticoagulant Reversal Agent Historic Market Size by Type (2021–2026)

4.2 Global Anticoagulant Reversal Agent Forecasted Market Size by Type (2027–2032)

5 Anticoagulant Reversal Agent Breakdown Data by Application

5.1 Global Anticoagulant Reversal Agent Historic Market Size by Application (2021–2026)

5.2 Global Anticoagulant Reversal Agent Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Anticoagulant Reversal Agent Market Size (2021–2032)

6.2 North America Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Anticoagulant Reversal Agent Market Size by Country (2021–2026)

6.4 North America Anticoagulant Reversal Agent Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Anticoagulant Reversal Agent Market Size (2021–2032)

7.2 Europe Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Anticoagulant Reversal Agent Market Size by Country (2021–2026)

7.4 Europe Anticoagulant Reversal Agent Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Anticoagulant Reversal Agent Market Size (2021–2032)

8.2 Asia-Pacific Anticoagulant Reversal Agent Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (2021–2026)

8.4 Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Anticoagulant Reversal Agent Market Size (2021–2032)

9.2 Latin America Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Anticoagulant Reversal Agent Market Size by Country (2021–2026)

9.4 Latin America Anticoagulant Reversal Agent Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Anticoagulant Reversal Agent Market Size (2021–2032)

10.2 Middle East & Africa Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2021–2026)

10.4 Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 DSM

11.1.1 DSM Company Details

11.1.2 DSM Business Overview

11.1.3 DSM Anticoagulant Reversal Agent Introduction

11.1.4 DSM Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.1.5 DSM Recent Development

11.2 AdvaCare

11.2.1 AdvaCare Company Details

11.2.2 AdvaCare Business Overview

11.2.3 AdvaCare Anticoagulant Reversal Agent Introduction

11.2.4 AdvaCare Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.2.5 AdvaCare Recent Development

11.3 Innopharma

11.3.1 Innopharma Company Details

11.3.2 Innopharma Business Overview

11.3.3 Innopharma Anticoagulant Reversal Agent Introduction

11.3.4 Innopharma Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.3.5 Innopharma Recent Development

11.4 Suicheng Pharmaceutical

11.4.1 Suicheng Pharmaceutical Company Details

11.4.2 Suicheng Pharmaceutical Business Overview

11.4.3 Suicheng Pharmaceutical Anticoagulant Reversal Agent Introduction

11.4.4 Suicheng Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.4.5 Suicheng Pharmaceutical Recent Development

11.5 Cheng Yi Pharmaceutical

11.5.1 Cheng Yi Pharmaceutical Company Details

11.5.2 Cheng Yi Pharmaceutical Business Overview

11.5.3 Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Introduction

11.5.4 Cheng Yi Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.5.5 Cheng Yi Pharmaceutical Recent Development

11.6 Wuhu Kangqi Pharmaceuticals

11.6.1 Wuhu Kangqi Pharmaceuticals Company Details

11.6.2 Wuhu Kangqi Pharmaceuticals Business Overview

11.6.3 Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Introduction

11.6.4 Wuhu Kangqi Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.6.5 Wuhu Kangqi Pharmaceuticals Recent Development

11.7 Jiangsu Huayang Pharmaceutical

11.7.1 Jiangsu Huayang Pharmaceutical Company Details

11.7.2 Jiangsu Huayang Pharmaceutical Business Overview

11.7.3 Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Introduction

11.7.4 Jiangsu Huayang Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.7.5 Jiangsu Huayang Pharmaceutical Recent Development

11.8 Brilliant Pharmaceutical

11.8.1 Brilliant Pharmaceutical Company Details

11.8.2 Brilliant Pharmaceutical Business Overview

11.8.3 Brilliant Pharmaceutical Anticoagulant Reversal Agent Introduction

11.8.4 Brilliant Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.8.5 Brilliant Pharmaceutical Recent Development

11.9 Shandong Guangtongbao Pharmaceuticals

11.9.1 Shandong Guangtongbao Pharmaceuticals Company Details

11.9.2 Shandong Guangtongbao Pharmaceuticals Business Overview

11.9.3 Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Introduction

11.9.4 Shandong Guangtongbao Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.9.5 Shandong Guangtongbao Pharmaceuticals Recent Development

11.10 Bayer AG

11.10.1 Bayer AG Company Details

11.10.2 Bayer AG Business Overview

11.10.3 Bayer AG Anticoagulant Reversal Agent Introduction

11.10.4 Bayer AG Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.10.5 Bayer AG Recent Development

11.11 Bristol-Myers Squibb Company

11.11.1 Bristol-Myers Squibb Company Company Details

11.11.2 Bristol-Myers Squibb Company Business Overview

11.11.3 Bristol-Myers Squibb Company Anticoagulant Reversal Agent Introduction

11.11.4 Bristol-Myers Squibb Company Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.11.5 Bristol-Myers Squibb Company Recent Development

11.12 Cambryn Biologics

11.12.1 Cambryn Biologics Company Details

11.12.2 Cambryn Biologics Business Overview

11.12.3 Cambryn Biologics Anticoagulant Reversal Agent Introduction

11.12.4 Cambryn Biologics Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.12.5 Cambryn Biologics Recent Development

11.13 eXithera Pharmaceuticals

11.13.1 eXithera Pharmaceuticals Company Details

11.13.2 eXithera Pharmaceuticals Business Overview

11.13.3 eXithera Pharmaceuticals Anticoagulant Reversal Agent Introduction

11.13.4 eXithera Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.13.5 eXithera Pharmaceuticals Recent Development

11.14 Ionis Pharmaceuticals

11.14.1 Ionis Pharmaceuticals Company Details

11.14.2 Ionis Pharmaceuticals Business Overview

11.14.3 Ionis Pharmaceuticals Anticoagulant Reversal Agent Introduction

11.14.4 Ionis Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)

11.14.5 Ionis Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

DSM

AdvaCare

Innopharma

Suicheng Pharmaceutical

Cheng Yi Pharmaceutical

Wuhu Kangqi Pharmaceuticals

Jiangsu Huayang Pharmaceutical

Brilliant Pharmaceutical

Shandong Guangtongbao Pharmaceuticals

Bayer

Bristol Myers Squibb Company

eXIthera Pharmaceuticals

Ionis Pharmaceuticals

Cambryn Biologics

List of Tables

Table 1. Global Anticoagulant Reversal Agent Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Injection Fluid

Table 3. Key Players of Tablet

Table 4. Key Players of Others

Table 5. Global Anticoagulant Reversal Agent Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Anticoagulant Reversal Agent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Anticoagulant Reversal Agent Market Size by Region (US$ Million), 2021–2026

Table 8. Global Anticoagulant Reversal Agent Market Share by Region (2021–2026)

Table 9. Global Anticoagulant Reversal Agent Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Anticoagulant Reversal Agent Market Share by Region (2027–2032)

Table 11. Anticoagulant Reversal Agent Market Trends

Table 12. Anticoagulant Reversal Agent Market Drivers

Table 13. Anticoagulant Reversal Agent Market Challenges

Table 14. Anticoagulant Reversal Agent Market Restraints

Table 15. Global Anticoagulant Reversal Agent Revenue by Players (US$ Million), 2021–2026

Table 16. Global Anticoagulant Reversal Agent Market Share by Players (2021–2026)

Table 17. Global Top Anticoagulant Reversal Agent Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anticoagulant Reversal Agent Revenue, 2025

Table 18. Ranking of Global Top Anticoagulant Reversal Agent Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Anticoagulant Reversal Agent Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Anticoagulant Reversal Agent, Headquarters and Area Served

Table 21. Global Key Players of Anticoagulant Reversal Agent, Products and Applications

Table 22. Global Key Players of Anticoagulant Reversal Agent, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Anticoagulant Reversal Agent Market Size by Type (US$ Million), 2021–2026

Table 25. Global Anticoagulant Reversal Agent Revenue Market Share by Type (2021–2026)

Table 26. Global Anticoagulant Reversal Agent Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Anticoagulant Reversal Agent Revenue Market Share by Type (2027–2032)

Table 28. Global Anticoagulant Reversal Agent Market Size by Application (US$ Million), 2021–2026

Table 29. Global Anticoagulant Reversal Agent Revenue Market Share by Application (2021–2026)

Table 30. Global Anticoagulant Reversal Agent Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Anticoagulant Reversal Agent Revenue Market Share by Application (2027–2032)

Table 32. North America Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026

Table 34. North America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Anticoagulant Reversal Agent Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032

Table 47. DSM Company Details

Table 48. DSM Business Overview

Table 49. DSM Anticoagulant Reversal Agent Product

Table 50. DSM Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 51. DSM Recent Development

Table 52. AdvaCare Company Details

Table 53. AdvaCare Business Overview

Table 54. AdvaCare Anticoagulant Reversal Agent Product

Table 55. AdvaCare Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 56. AdvaCare Recent Development

Table 57. Innopharma Company Details

Table 58. Innopharma Business Overview

Table 59. Innopharma Anticoagulant Reversal Agent Product

Table 60. Innopharma Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 61. Innopharma Recent Development

Table 62. Suicheng Pharmaceutical Company Details

Table 63. Suicheng Pharmaceutical Business Overview

Table 64. Suicheng Pharmaceutical Anticoagulant Reversal Agent Product

Table 65. Suicheng Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 66. Suicheng Pharmaceutical Recent Development

Table 67. Cheng Yi Pharmaceutical Company Details

Table 68. Cheng Yi Pharmaceutical Business Overview

Table 69. Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Product

Table 70. Cheng Yi Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 71. Cheng Yi Pharmaceutical Recent Development

Table 72. Wuhu Kangqi Pharmaceuticals Company Details

Table 73. Wuhu Kangqi Pharmaceuticals Business Overview

Table 74. Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Product

Table 75. Wuhu Kangqi Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 76. Wuhu Kangqi Pharmaceuticals Recent Development

Table 77. Jiangsu Huayang Pharmaceutical Company Details

Table 78. Jiangsu Huayang Pharmaceutical Business Overview

Table 79. Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Product

Table 80. Jiangsu Huayang Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 81. Jiangsu Huayang Pharmaceutical Recent Development

Table 82. Brilliant Pharmaceutical Company Details

Table 83. Brilliant Pharmaceutical Business Overview

Table 84. Brilliant Pharmaceutical Anticoagulant Reversal Agent Product

Table 85. Brilliant Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 86. Brilliant Pharmaceutical Recent Development

Table 87. Shandong Guangtongbao Pharmaceuticals Company Details

Table 88. Shandong Guangtongbao Pharmaceuticals Business Overview

Table 89. Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Product

Table 90. Shandong Guangtongbao Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 91. Shandong Guangtongbao Pharmaceuticals Recent Development

Table 92. Bayer AG Company Details

Table 93. Bayer AG Business Overview

Table 94. Bayer AG Anticoagulant Reversal Agent Product

Table 95. Bayer AG Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 96. Bayer AG Recent Development

Table 97. Bristol-Myers Squibb Company Company Details

Table 98. Bristol-Myers Squibb Company Business Overview

Table 99. Bristol-Myers Squibb Company Anticoagulant Reversal Agent Product

Table 100. Bristol-Myers Squibb Company Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 101. Bristol-Myers Squibb Company Recent Development

Table 102. Cambryn Biologics Company Details

Table 103. Cambryn Biologics Business Overview

Table 104. Cambryn Biologics Anticoagulant Reversal Agent Product

Table 105. Cambryn Biologics Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 106. Cambryn Biologics Recent Development

Table 107. eXithera Pharmaceuticals Company Details

Table 108. eXithera Pharmaceuticals Business Overview

Table 109. eXithera Pharmaceuticals Anticoagulant Reversal Agent Product

Table 110. eXithera Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 111. eXithera Pharmaceuticals Recent Development

Table 112. Ionis Pharmaceuticals Company Details

Table 113. Ionis Pharmaceuticals Business Overview

Table 114. Ionis Pharmaceuticals Anticoagulant Reversal Agent Product

Table 115. Ionis Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026

Table 116. Ionis Pharmaceuticals Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Anticoagulant Reversal Agent Picture

Figure 2. Global Anticoagulant Reversal Agent Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Anticoagulant Reversal Agent Market Share by Type: 2025 vs 2032

Figure 4. Injection Fluid Features

Figure 5. Tablet Features

Figure 6. Others Features

Figure 7. Global Anticoagulant Reversal Agent Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Anticoagulant Reversal Agent Market Share by Application: 2025 vs 2032

Figure 9. Hospital Case Studies

Figure 10. Research Institute Case Studies

Figure 11. Others Case Studies

Figure 12. Anticoagulant Reversal Agent Report Years Considered

Figure 13. Global Anticoagulant Reversal Agent Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Anticoagulant Reversal Agent Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Anticoagulant Reversal Agent Market Share by Region: 2025 vs 2032

Figure 16. Global Anticoagulant Reversal Agent Market Share by Players in 2025

Figure 17. Global Anticoagulant Reversal Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Anticoagulant Reversal Agent Revenue in 2025

Figure 19. North America Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Anticoagulant Reversal Agent Market Share by Country (2021–2032)

Figure 21. United States Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Anticoagulant Reversal Agent Market Share by Country (2021–2032)

Figure 25. Germany Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Anticoagulant Reversal Agent Market Share by Region (2021–2032)

Figure 33. China Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Anticoagulant Reversal Agent Market Share by Country (2021–2032)

Figure 41. Mexico Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Anticoagulant Reversal Agent Market Share by Country (2021–2032)

Figure 45. Israel Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. DSM Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 49. AdvaCare Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 50. Innopharma Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 51. Suicheng Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 52. Cheng Yi Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 53. Wuhu Kangqi Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 54. Jiangsu Huayang Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 55. Brilliant Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 56. Shandong Guangtongbao Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 57. Bayer AG Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 59. Cambryn Biologics Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 60. eXithera Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 61. Ionis Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anticoagulant Drugs Market Insights Forecast to 2030

Global Anticoagulant Reversal Drug Market Insights Forecast to 2030

Global Anticoagulant Treatment Market Insights Forecast to 2030

Anticoagulants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Heparin Anticoagulant Market Insights Forecast to 2028

Anticoagulant Reversal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anticoagulant Medicines Market Research Report 2025

Global Oral Anticoagulants Market Research Report 2024

Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2030

Global Antithrombotic Treatment Market Insights Forecast to 2030

Global Oral Anticoagulant Reversal Drug Market Research Report 2025

Global Heparin Market Insights Forecast to 2030

Global Injectable Blood Thinners Market Research Report 2025

Global Intravenous Anticoagulants Market Research Report 2024

Global Factor Xa Inhibitors Market Research Report 2024

Global Rivaroxaban Drugs Market Research Report 2024

Sodium Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Thrombosis Drug Market Research Report 2025

Global Heparin Sodium Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions